Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/445Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Abdullah, S Tarique | - |
| dc.contributor.author | Hamid, Hinna | - |
| dc.contributor.author | Ali, Mohammad | - |
| dc.contributor.author | Ansari, S H | - |
| dc.contributor.author | Alam, M Sarwar | - |
| dc.date.accessioned | 2008-03-20T11:36:49Z | - |
| dc.date.available | 2008-03-20T11:36:49Z | - |
| dc.date.issued | 2007-01 | - |
| dc.identifier.issn | 0376-4699 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/445 | - |
| dc.description | 173-176 | en_US |
| dc.description.abstract | The lichen Parmelia perlata has yielded a new lanost-2-en type triterpene, named parmelanostene and a new labdane type diterpenoid, named permelabdone, identified on the basis of spectroscopic studies as 29, 30-nordimethyl-lanost-2-en 1 and 2'-methoxyphenyl-19-[4α, 8β, 10β-trimethyl-9-(13-methyl butyl)-decahydronapthalen-4-yl]-20-methoxybenzoate 2, respectively which were also found to have antibacterial potential against S. aureus and E. coli bacterial strains. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | NISCAIR | en_US |
| dc.relation.ispartofseries | Int.Cl⁸ A61K | en_US |
| dc.source | IJCB Vol.46B(1) [January 2007] | en_US |
| dc.subject | Lichen | en_US |
| dc.subject | Labdane | en_US |
| dc.subject | Diterpenoid | en_US |
| dc.subject | Permelabdone | en_US |
| dc.subject | Antibacterial | en_US |
| dc.subject | 29, 30-nordimethyl-lanost-2-en | en_US |
| dc.subject | 2'-methoxyphenyl-19-[4α, 8β, 10β-trimethyl-9-(13-methyl butyl)-decahydronapthalen-4-yl]-20-methoxybenzoate | en_US |
| dc.title | Two new terpenes from the lichen Parmelia perlata | en_US |
| Appears in Collections: | IJC-B Vol.46B(01) [January 2007] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJCB 46B(1) (2007) 173-176.pdf | 66.44 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.